Quadria-Backed Maxivision Takes Confidential Route Toward India IPO

Mumbai, 2 October 2026 – Maxivision Eye Hospitals has confidentially filed draft documents for an initial public offering in India, moving the Quadria Capital-backed healthcare group closer to the public market while retaining flexibility over timing and deal structure. A public notice confirmed the filing, although the confidential route means the offer size, valuation and detailed financial disclosures are not yet available to investors.

The process allows a prospective issuer to receive regulatory feedback before publishing a full prospectus. It can be useful when markets are volatile because the company is not required to disclose all transaction details at the outset and can refine the offering before formally launching it. For Maxivision, that optionality matters as Indian equity markets balance strong demand for healthcare exposure against close scrutiny of valuations and profitability.